Phathom Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

Rhea-AI Summary

Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT) has announced that its management team will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on June 1, 2021, at 10:00 a.m. ET. The conference runs from June 1-4, 2021, during which management will also engage in one-on-one meetings. Investors can access a live webcast and archived recording via the Phathom website, available for 90 days post-event. Phathom focuses on developing treatments for gastrointestinal diseases, with exclusive rights to vonoprazan for acid-related disorders.

FLORHAM PARK, N.J., May 25, 2021 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that members of the management team will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 at 10:00 a.m. ET.  

Company management will also participate in one-on-one meetings during the virtual conference which runs from June 1-4, 2021.

To access the live webcast and archived recording of the presentation, visit the News & Events section of the Phathom website at https://investors.phathompharma.com/news-events/events-and-presentations. The recording will be available for 90 days following the event.

About Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. Phathom has in-licensed the exclusive rights in the United States, Europe, and Canada to vonoprazan, a novel potassium competitive acid blocker (P-CAB) in late-stage development for the treatment of acid-related disorders. For more information about Phathom, visit the Company’s website at www.phathompharma.com or follow the Company on social media: LinkedIn at www.linkedin.com/company/phathompharma and Twitter @PhathomPharma.

CONTACTS
Media Contact:
Nick Benedetto
1-877-742-8466
media@phathompharma.com

Investor Contact:
Todd Branning
1-877-742-8466
ir@phathompharma.com

FAQ

When is the Phathom Pharmaceuticals fireside chat at the Jefferies Virtual Healthcare Conference?

The fireside chat will take place on June 1, 2021, at 10:00 a.m. ET.

What is the duration of the Jefferies Virtual Healthcare Conference for Phathom?

The conference runs from June 1-4, 2021.

How can I access the Phathom Pharmaceuticals webcast from the conference?

You can access the webcast and archived recording on the Phathom website's News & Events section.

What is Phathom Pharmaceuticals' focus area in biopharmaceuticals?

Phathom Pharmaceuticals focuses on developing treatments for gastrointestinal diseases.

What drug is Phathom developing for acid-related disorders?

Phathom is developing vonoprazan, a novel potassium competitive acid blocker.